Patents by Inventor Joe D. Cohen

Joe D. Cohen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Recombinant merozoite protein-1vaccine
    Patent number: 8211447
    Abstract: In this application is described the expression and purification of a recombinant Plasmodium falciparum (FVO) MSP-142. The method of the present invention produces a highly purified protein that retains folding and disulfide bridging of the native molecule. The recombinant MSP-142 is useful as a diagnostic reagent, for use in antibody production, and as a vaccine.
    Type: Grant
    Filed: July 21, 2009
    Date of Patent: July 3, 2012
    Assignee: The United States of America as represented by the Secretary of the Army
    Inventors: Evelina Angov, Jeffrey A. Lyon, Christian Asare Darko, Joe D. Cohen
  • RECOMBINANT P. FALCIPARUM MEROZOITE PROTEIN-142 VACCINE
    Publication number: 20100028386
    Abstract: In this application is described the expression and purification of a recombinant Plasmodium falciparum (FVO) MSP-142. The method of the present invention produces a highly purified protein that retains folding and disulfide bridging of the native molecule. The recombinant MSP-142 is useful as a diagnostic reagent, for use in antibody production, and as a vaccine.
    Type: Application
    Filed: July 21, 2009
    Publication date: February 4, 2010
    Applicant: United States Army Medical Research Command,
    Inventors: Evelina Angov, Jeffrey A. Lyon, Christian Asare, Joe D. Cohen
  • Recombinant merozoite protein-1vaccine
    Patent number: 7563883
    Abstract: In this application is described the expression and purification of a recombinant Plasmodium falciparum (FVO) MSP-142. The method of the present invention produces a highly purified protein that retains folding and disulfide bridging of the native molecule. The recombinant MSP-142 is useful as a diagnostic reagent, for use in antibody production, and as a vaccine.
    Type: Grant
    Filed: August 14, 2007
    Date of Patent: July 21, 2009
    Assignee: The United States of America as represented by the Secretary of the Army
    Inventors: Evelina Angov, Jeffrey A. Lyon, Christian Asare Darko, Joe D. Cohen
  • Recombinant merozoite protein-142 vaccine
    Patent number: 7306806
    Abstract: In this application is the expression and purification of a recombinant Plasmodium falciparum (3D7) MSP-142. The method of the present invention produces a highly purified protein which retains folding and disulfide bridging of the native molecule. The recombinant MSP-142 is useful as a diagnostic reagent, for use in antibody production, and as a vaccine.
    Type: Grant
    Filed: January 25, 2002
    Date of Patent: December 11, 2007
    Assignee: United States of America as represented by the Secretary of the Army
    Inventors: Jeffrey A. Lyon, Evelina Angov, Joe D. Cohen, Gerald Voss
  • Recombinant merozoite protein-1vaccine
    Patent number: 7256281
    Abstract: In this application is described the expression and purification of a recombinant Plasmodium falciparum (FVO) MSP-142. The method of the present invention produces a highly purified protein that retains folding and disulfide bridging of the native molecule. The recombinant MSP-142 is useful as a diagnostic reagent, for use in antibody production, and as a vaccine.
    Type: Grant
    Filed: April 1, 2003
    Date of Patent: August 14, 2007
    Assignees: United States of America as represented by the Secretary of the Army
    Inventors: Evelina Angov, Jeffrey A. Lyon, Christian Asare Darko, Joe D. Cohen
  • Recombinant P. falciparum merozoite protein-142 vaccine
    Publication number: 20040005332
    Abstract: In this application is described the expression and purification of a recombinant Plasmodium falciparum (FVO) MSP-142. The method of the present invention produces a highly purified protein that retains folding and disulfide bridging of the native molecule. The recombinant MSP-142 is useful as a diagnostic reagent, for use in antibody production, and as a vaccine.
    Type: Application
    Filed: April 1, 2003
    Publication date: January 8, 2004
    Inventors: Evelina Angov, Jeffrey A. Lyon, Christian Asare Darko, Joe D. Cohen
  • Recombinant P. falciparum merozoite protein-142 vaccine
    Publication number: 20030161839
    Abstract: In this application is the expression and purification of a recombinant Plasmodium falciparum (3D7) MSP-142. The method of the present invention produces a highly purified protein which retains folding and disulfide bridging of the native molecule. The recombinant MSP-142 is useful as a diagnostic reagent, for use in antibody production, and as a vaccine.
    Type: Application
    Filed: January 25, 2002
    Publication date: August 28, 2003
    Inventors: Jeffrey A. Lyon, Evelina Angov, Joe D. Cohen, Gerald Voss